Are we on the cusp of a cancer care revolution?
Recent developments in cancer therapy have been called transformational, but they are often very expensive, and some doctors caution against over-estimating their potential benefits
This year, regulators approved the first gene therapy treatment for cancer. Using this landmark treatment, a patient’s own cells are turbo-charged outside the body, reinjected, then used to attack cancer - like tiny, but effective, tumour assassins.
Drug companies are selling tests for thousands of euro that can provide the unique genomic profile of an individual patient’s tumour. The reason? Instead of blasting cancer patients with chemotherapy and radiation that destroy everything in ...
